Caux C - Search Results

1

Targeting pattern recognition receptors in cancer immunotherapy.

Goutagny N, Estornes Y, Hasan U, Lebecque S, Caux C. Goutagny N, et al. Among authors: caux c. Target Oncol. 2012 Mar;7(1):29-54. doi: 10.1007/s11523-012-0213-1. Epub 2012 Mar 8. Target Oncol. 2012. PMID: 22399234 Review.

2

Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines.

Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. Dieu-Nosjean MC, et al. Among authors: caux c. J Leukoc Biol. 1999 Aug;66(2):252-62. doi: 10.1002/jlb.66.2.252. J Leukoc Biol. 1999. PMID: 10449163 Review.

3

Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.

de Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, Trinchieri G, Bates EE, Caux C. de Bouteiller O, et al. Among authors: caux c. J Biol Chem. 2005 Nov 18;280(46):38133-45. doi: 10.1074/jbc.M507163200. Epub 2005 Sep 6. J Biol Chem. 2005. PMID: 16144834 Free article.

4

Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria.

Flacher V, Bouschbacher M, Verronèse E, Massacrier C, Sisirak V, Berthier-Vergnes O, de Saint-Vis B, Caux C, Dezutter-Dambuyant C, Lebecque S, Valladeau J. Flacher V, et al. Among authors: caux c. J Immunol. 2006 Dec 1;177(11):7959-67. doi: 10.4049/jimmunol.177.11.7959. J Immunol. 2006. PMID: 17114468

5

Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs.

Hasan UA, Caux C, Perrot I, Doffin AC, Menetrier-Caux C, Trinchieri G, Tommasino M, Vlach J. Hasan UA, et al. Among authors: caux c. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8047-52. doi: 10.1073/pnas.0700664104. Epub 2007 Apr 26. Proc Natl Acad Sci U S A. 2007. PMID: 17463087 Free PMC article.

6

Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer.

Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D. Hirsch I, et al. Among authors: caux c. Trends Immunol. 2010 Oct;31(10):391-7. doi: 10.1016/j.it.2010.07.004. Epub 2010 Sep 9. Trends Immunol. 2010. PMID: 20832362 Review.

7

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.

Cassier PA, Treilleux I, Bachelot T, Ray-Coquard I, Bendriss-Vermare N, Ménétrier-Caux C, Trédan O, Goddard-Léon S, Pin JJ, Mignotte H, Bathélémy-Dubois C, Caux C, Lebecque S, Blay JY. Cassier PA, et al. Among authors: caux c. BMC Cancer. 2011 May 30;11:213. doi: 10.1186/1471-2407-11-213. BMC Cancer. 2011. PMID: 21624121 Free PMC article.

8

Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.

Faget J, Biota C, Bachelot T, Gobert M, Treilleux I, Goutagny N, Durand I, Léon-Goddard S, Blay JY, Caux C, Ménétrier-Caux C. Faget J, et al. Among authors: caux c. Cancer Res. 2011 Oct 1;71(19):6143-52. doi: 10.1158/0008-5472.CAN-11-0573. Epub 2011 Aug 18. Cancer Res. 2011. PMID: 21852386

9

Targeting regulatory T cells.

Ménétrier-Caux C, Curiel T, Faget J, Manuel M, Caux C, Zou W. Ménétrier-Caux C, et al. Among authors: caux c. Target Oncol. 2012 Mar;7(1):15-28. doi: 10.1007/s11523-012-0208-y. Epub 2012 Feb 12. Target Oncol. 2012. PMID: 22327882 Review.

10

Recent successes of cancer immunotherapy: a new dimension in personalized medicine?

Caux C, Zitvogel L. Caux C, et al. Target Oncol. 2012 Mar;7(1):1-2. doi: 10.1007/s11523-012-0211-3. Epub 2012 Feb 15. Target Oncol. 2012. PMID: 22350488 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters